Module title: Therapeutic Options for Malignant Haematological Disorders (40 credits)

SCQF level: 11:
SCQF credit value: 40.00
ECTS credit value: 20

Module code: NMS11191
Module leader: Emma Trotter
School School of Health & Social Care
Subject area group: Cancer Collaborative
Prerequisites

N/A

2019/0, Trimester 2, Online,
Occurrence: 001
Primary mode of delivery: Online
Location of delivery: SIGHTHILL
Partner:
Member of staff responsible for delivering module: Emma Trotter
Module Organiser:


Learning, Teaching and Assessment (LTA) Approach:
This module encourages you to learn independently through your participation in a range of VLE based activities within Moodle and Webinar facilities with support from your academic supervisor and peer group. You will critically reflect on the literature relevant to the pathophysiology of disease and its treatment in relation to your clinical practice (LO1-2). You will participate in discussion boards and Webinar with other colleagues to enhance deeper learning on specific subjects and encourage collaboration and networking (LO 3). The VLE materials have been designed to provide you with autonomy on the how and when you learn. By this we mean there is a variety of learning approaches taken for example – reflection on; case studies, suggested reading and listening to audio and video material (LO 4, 5). Academic support to disseminate new found knowledge (LO 6).

Embedding of employability/PDP/Scholarship Skills
This module will combine traditional intellectual and analytical skills with reflective skills. The use of Moodle and Webinar facilities contributes towards core transferable skills in information technology and group participation over the Internet. The course is seen as important assets to the East of Scotland Haematology Nursing Group, and holds importance within clinical practice due to an organisational commitment linking education of nursing staff (Band 6 and 7) and accreditation to perform patient care. The assignments have been developed and designed to aid the student in enhancing clinical practice by looking at treatment and research in depth. The student can also use the content of the course in application of their knowledge toward their personal development plans and knowledge skills framework in the core domains and the Health and Wellbeing


Formative Assessment:
Formative assessment takes the form of quizzes, and online Tutorials within Moodle, summative assessment feedback (LO1- 6).

Summative Assessment:
Write 1 Essay’s (each 3,500 words), (50%) (Submitted by week 28).
Produce an academic poster or presentation (50%) (Submitted by week 28).



Student Activity (Notional Equivalent Study Hours (NESH))
Mode of activityLearning & Teaching ActivityNESH (Study Hours)
Online Guided independent study 380
Online Lecture 10
Online Groupwork (Scheduled) 10
Total Study Hours400
Expected Total Study Hours for Module400


Assessment
Type of Assessment Weighting % LOs covered Week due Length in Hours/Words
Essay 50 1,2,3,4,5 14 HOURS= 0, WORDS= 3500
Poster 50 6 28 HOURS= 0, WORDS= 0
Component 1 subtotal: 50
Component 2 subtotal: 50
Module subtotal: 100

Description of module content:

Unit 1a: Introduction to the student learning environment and establish support structure from module team, Napier university and fellow students through a variety of activities.
Introduction to the module design and delivery of the learning materials; incorporating the introduction to depth and breadth of these materials used throughout the module. There is a refresher folder available for students to revisit their knowledge of blood physiology, chemotherapy, radiotherapy, nutrition, virology, immunology and bacteriology. Placing haematology in the context of cancer care.

Unit 1b: Studying on line material: therapeutic options for Leukaemia’s, Lymphomas, and Myeloma, including new novel treatments, clinical trials and complication of treatment.

Unit 2: Bone marrow transplantation, peripheral stem cell transplantation, complications of treatments. Psychosocial issues (including treatment, survivorship and rehabilitation), ethical implications, the multidisciplinary team approach, family involvement, donor issues, emergency care and end of life issues.

Learning Outcomes for module:

Upon completion of this module you will be able to:
LO1 Evaluate haematological patho-physiology and epidemiology in relation to clinical practice.
LO2. Critically explore the treatment options and outcomes for an individual, undergoing chemotherapy, radiotherapy, immune therapy, bone marrow or peripheral stem cell transplant.
LO3. Critically engage with the psychosocial, ethical, and end of life implications for a person in relation to treatment.
LO4. Evaluate the importance of the role of the health professional within the multidisciplinary team.
LO5. Appraise developments in evidence-based practice and the potential of these to inform current clinical practice.
LO6: Demonstrate dissemination of new found knowledge and learning

Indicative References and Reading List - URL:

Please contact your Module Leader for details
Click here to view the LibrarySearch.